The AML samples represented the subgroups NPM1-mutated, AML-MR, TP53-mutated, CBFB::MYH11, RUNX1::RUNX1T1, AML without class-defining mutations, and AML meeting criteria for two subgroups. Here, TP53 is linked to acute myeloid leukemia.